The Impact of a 1-Day Multidisciplinary Prostate Cancer Clinic on Patients' Choice of Treatment.
J Am Coll Radiol. 2018 Dec;15(12):1745-1748. doi: 10.1016/j.jacr.2018.06.023. Epub 2018 Aug 3.
Cushman TR1, Mashni J2, Roberts T3, Kumar R4.
Prostate cancer is the most common solid malignancy in men in the United States, affecting an estimated 240,000 men each year . Fortunately, it is typically a slow-progressing cancer, and only approximately 14% of men with prostate cancer will die from the disease . There is no clear evidence demonstrating improved survival from definitive treatment in patients with low-risk prostate cancer, which has led to controversy in how to best manage this group . The National Comprehensive Cancer Network treatment recommendations for low-risk prostate cancer with a life expectancy of 10 or more years include active surveillance (prostate-specific antigen monitoring, yearly digital rectal examination, and biopsy), external-beam radiation therapy, brachytherapy, or even radical prostatectomy . For intermediate- and high-risk patients, treatment recommendations are similarly diverse, and also include androgen deprivation therapy.